Research ArticleOncology
Open Access
PET Imaging of PARP Expression Using 18F-Olaparib
Thomas C. Wilson, Mary-Ann Xavier, James Knight, Stefan Verhoog, Julia Baguña Torres, Michael Mosley, Samantha L. Hopkins, Sheena Wallington, Phillip D. Allen, Veerle Kersemans, Rebekka Hueting, Sean Smart, Véronique Gouverneur and Bart Cornelissen
Journal of Nuclear Medicine April 2019, 60 (4) 504-510; DOI: https://doi.org/10.2967/jnumed.118.213223
Thomas C. Wilson
1Department of Chemistry, University of Oxford, Oxford, United Kingdom; and
Mary-Ann Xavier
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
James Knight
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Stefan Verhoog
1Department of Chemistry, University of Oxford, Oxford, United Kingdom; and
Julia Baguña Torres
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Michael Mosley
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Samantha L. Hopkins
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Sheena Wallington
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Phillip D. Allen
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Veerle Kersemans
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Rebekka Hueting
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Sean Smart
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
Véronique Gouverneur
1Department of Chemistry, University of Oxford, Oxford, United Kingdom; and
Bart Cornelissen
2CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 4
April 1, 2019
PET Imaging of PARP Expression Using 18F-Olaparib
Thomas C. Wilson, Mary-Ann Xavier, James Knight, Stefan Verhoog, Julia Baguña Torres, Michael Mosley, Samantha L. Hopkins, Sheena Wallington, Phillip D. Allen, Veerle Kersemans, Rebekka Hueting, Sean Smart, Véronique Gouverneur, Bart Cornelissen
Journal of Nuclear Medicine Apr 2019, 60 (4) 504-510; DOI: 10.2967/jnumed.118.213223
PET Imaging of PARP Expression Using 18F-Olaparib
Thomas C. Wilson, Mary-Ann Xavier, James Knight, Stefan Verhoog, Julia Baguña Torres, Michael Mosley, Samantha L. Hopkins, Sheena Wallington, Phillip D. Allen, Veerle Kersemans, Rebekka Hueting, Sean Smart, Véronique Gouverneur, Bart Cornelissen
Journal of Nuclear Medicine Apr 2019, 60 (4) 504-510; DOI: 10.2967/jnumed.118.213223
Jump to section
Related Articles
Cited By...
- [123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
- [18F]-Labeled PARP-1 PET Imaging of PSMA Targeted Alpha Particle Radiotherapy Response
- Molecular Imaging: PARP-1 and Beyond
- PARP Inhibitors in Cancer Diagnosis and Therapy
- Preclinical and first-in-human-brain-cancer applications of [18F]poly-(ADP-ribose) polymerase inhibitor PET/MR
- Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
- PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer
- Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer